News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
174 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21249)
Month
January (3049)
February (3199)
March (3214)
April (3461)
May (3810)
June (3552)
July (3330)
August (2848)
September (3192)
October (3888)
November (3400)
December (2467)
Day
1 (145)
4 (171)
5 (157)
6 (167)
7 (193)
8 (124)
11 (153)
12 (168)
13 (176)
14 (165)
15 (127)
18 (80)
19 (163)
20 (160)
21 (172)
22 (114)
25 (160)
26 (149)
27 (150)
28 (174)
29 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
25
26
27
28
29
Policy
FDA Issues Not-Approvable Letter for Eli Lilly and Company’s Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
February 28, 2008
·
7 min read
Business
Merck & Co., Inc. Keeps Rights to Certain AstraZeneca PLC Drugs
February 28, 2008
·
2 min read
FDA
Boca Pharmacal, Inc. Receives FDA Approval for Carbinoxamine Oral Solution
February 28, 2008
·
1 min read
Drug Development
Arriva Pharmaceuticals, Inc. Moves Forward to Phase 2b Development of Lead Inhaled Protein rAAT
February 28, 2008
·
2 min read
FDA
FDA Approves AstraZeneca PLC’s NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
February 28, 2008
·
7 min read
Drug Development
Evotec AG Starts Phase II in Smoking Cessation with EVT 302
February 28, 2008
·
3 min read
Policy
Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002)
February 28, 2008
·
2 min read
FDA
FDA Clears Veridex, LLC Cellsearch(TM) Circulating Tumor Cell Test for Monitoring Metastatic Prostate Cancer Patients
February 28, 2008
·
5 min read
Drug Development
Novartis Pharmaceuticals Corporation’s Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
February 28, 2008
·
7 min read
Drug Development
NeurogesX, Inc. Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP Primary and Secondary Endpoints Do Not Achieve Statistical Significance
February 28, 2008
·
9 min read
1 of 18
Next